These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Astrinidis A, Henske EP. Oncogene; 2005 Nov 14; 24(50):7475-81. PubMed ID: 16288294 [Abstract] [Full Text] [Related]
26. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex. Mizuguchi M. Congenit Anom (Kyoto); 2007 Mar 14; 47(1):2-8. PubMed ID: 17300684 [Abstract] [Full Text] [Related]
27. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex. Ali M, Girimaji SC, Markandaya M, Shukla AK, Sacchidanand S, Kumar A. Acta Neurol Scand; 2005 Jan 14; 111(1):54-63. PubMed ID: 15595939 [Abstract] [Full Text] [Related]
28. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients. Goedbloed MA, Nellist M, Verhaaf B, Reuser AJ, Lindhout D, Sunde L, Verhoef S, Halley DJ, van den Ouweland AM. Eur J Hum Genet; 2001 Nov 14; 9(11):823-8. PubMed ID: 11781698 [Abstract] [Full Text] [Related]
29. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. Hung CC, Su YN, Chien SC, Liou HH, Chen CC, Chen PC, Hsieh CJ, Chen CP, Lee WT, Lin WL, Lee CN. BMC Med Genet; 2006 Sep 18; 7():72. PubMed ID: 16981987 [Abstract] [Full Text] [Related]
30. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, Fukuchi Y, Hino O. J Hum Genet; 2002 Sep 18; 47(1):20-8. PubMed ID: 11829138 [Abstract] [Full Text] [Related]
34. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer. Kataoka K, Fujimoto K, Ito D, Koizumi M, Toyoda E, Mori T, Kami K, Doi R. Surgery; 2005 Sep 18; 138(3):450-5. PubMed ID: 16213898 [Abstract] [Full Text] [Related]
35. Hamartin and tuberin expression in human tissues. Johnson MW, Kerfoot C, Bushnell T, Li M, Vinters HV. Mod Pathol; 2001 Mar 18; 14(3):202-10. PubMed ID: 11266527 [Abstract] [Full Text] [Related]
36. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Jansen FE, Braams O, Vincken KL, Algra A, Anbeek P, Jennekens-Schinkel A, Halley D, Zonnenberg BA, van den Ouweland A, van Huffelen AC, van Nieuwenhuizen O, Nellist M. Neurology; 2008 Mar 18; 70(12):908-15. PubMed ID: 18032745 [Abstract] [Full Text] [Related]
37. Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations. Yamashita Y, Ono J, Okada S, Wataya-Kaneda M, Yoshikawa K, Nishizawa M, Hirayama Y, Kobayashi E, Seyama K, Hino O. Am J Med Genet; 2000 Jan 17; 90(2):123-6. PubMed ID: 10607950 [Abstract] [Full Text] [Related]
38. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Plank TL, Yeung RS, Henske EP. Cancer Res; 1998 Nov 01; 58(21):4766-70. PubMed ID: 9809973 [Abstract] [Full Text] [Related]
40. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Wienecke R, Maize JC, Reed JA, de Gunzburg J, Yeung RS, DeClue JE. Am J Pathol; 1997 Jan 01; 150(1):43-50. PubMed ID: 9006320 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]